# US 2024/0182958 A1 · Novel compositions, methods and kits for real time polymerase chain reaction (pcr)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0182958 A1
- Document ID: US20240182958A1
- Status: Published application
- Kind: A1
- Application number: 18/465,581
- Filed: 2023-09-12
- Published: 2024-06-06
- Earliest claimed: 2012-06-14
- Assignees: Life Technologies Corporation
- Applicants: Life Technologies Corporation
- Inventors: Carole BORNARTH; Michael LAU; Junko STEVENS
- Web page: https://patentgrep.com/patent/US20240182958A1

## CPC

- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C12N 9/00: Enzymes; Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K8/66, A61Q11/00; medicinal preparations containing enzymes or proenzymes A61K38/43; enzyme containing detergent compositions C11D; {enzymes with nucleic acid structure, e.g. ribozymes, C12N15/113}); Processes for preparing, activating, inhibiting, separating or purifying enzymes (preparation of malt C12C1/00)
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present disclosure is directed to compositions, methods and kits for amplifying target nucleic acids while reducing non-specific amplification and undesired amplification products using a dual hot start reaction mixture that comprise at least two different hot start mechanisms.

## Claims

### Claim at position 1

1-11. (canceled)

### Claim 12

A method for amplifying a target nucleic acid comprising:
a) contacting the target nucleic acid with a nucleic acid polymerase, a dual hot start reaction mixture, at least one primer and at least one dNTP at a first temperature, thereby forming a reaction composition;
b) heating the reaction composition to a second temperature; and
c) amplifying the target nucleic acid in the reaction composition.

### Claim 13 (depends on 12)

The method of claim 12, wherein the nucleic acid polymerase is thermostable.

### Claim at position 4

14-17. (canceled)

### Claim 18

A kit, comprising:
a nucleic acid polymerase; and
a dual hot start reaction mixture, the dual hot start reaction mixture including two different hot start mechanisms that collectively are capable of substantially reducing formation of non-specific amplification products polymerase activity of the nucleic acid polymerase at ambient temperature,
one of the two different hot start mechanisms including an antibody-based hot start mechanism.

### Claim 19 (depends on 18)

The kit of claim 18, further comprising:
an amplification mixture including at least one primer, dNTPs, and a nucleic acid binding dye,
the dual hot start reaction mixture and the nucleic acid polymerase forming a pre-amplification mixture, and
the amplification mixture and the pre-amplification mixture being in a separate container than the pre-amplification mixture.

### Claim 20

(canceled)

### Claim 21 (depends on 18)

The kit of claim 18, further comprising:
an amplification mixture including at least one primer, dNTPs, and a nucleic acid binding dye,
the amplification mixture, the nucleic acid polymerase and the dual hot start reaction mixture being in a first container.

### Claim 22 (depends on 18)

The kit of claim 18, wherein the nucleic acid polymerase is a DNA-dependent DNA polymerase or an RNA-dependent DNA polymerase.

### Claim 23 (depends on 18)

The kit of claim 18, wherein the nucleic acid polymerase is thermostable.

### Claim 24

The kit of 18, wherein the nucleic acid polymerase comprises a polymerase selected from the group consisting of Taq DNA polymerase, Tfl DNA polymerase, Tfi DNA polymerase, Pfu DNA polymerase, and mutants or derivatives thereof.

### Claim 25 (depends on 18)

The kit of claim 18, wherein another of the two different hot start mechanisms is selected from the group consisting of oligonucleotides that block polymerase activity at lower temperatures, reversible chemical modifications of the thermostable nucleic acid polymerase that dissociate at elevated temperatures, amino acid modifications of the thermostable nucleic acid polymerase that provide reduced activity at lower temperatures, fusion proteins that include hyperstable nucleic acid binding domains and topoisomerase, temperature-dependent ligands that inhibit polymerase activity, single-stranded binding proteins that sequester primers at lower temperatures, modified primers, and modified dNTPs.

### Claim 26

A dual hot start reaction mixture, comprising:
two different hot start mechanisms that collectively are capable of substantially reducing formation of non-specific amplification products polymerase activity of a nucleic acid polymerase at ambient temperature,
one of the two different hot start mechanisms including an antibody-based hot start mechanism.

### Claim 27 (depends on 26)

The dual hot start reaction mixture of claim 26, wherein another of the two different hot start mechanisms is selected from the group consisting of oligonucleotides that block polymerase activity at lower temperatures, reversible chemical modifications of the thermostable nucleic acid polymerase that dissociate at elevated temperatures, amino acid modifications of the thermostable nucleic acid polymerase that provide reduced activity at lower temperatures, fusion proteins that include hyperstable nucleic acid binding domains and topoisomerase, temperature-dependent ligands that inhibit polymerase activity, single-stranded binding proteins that sequester primers at lower temperatures, modified primers, and modified dNTPs.

### Claim 28 (depends on 26)

The dual hot start reaction mixture of claim 26, wherein the nucleic acid polymerase is a DNA-dependent DNA polymerase or an RNA-dependent DNA polymerase.

### Claim 29 (depends on 26)

The dual hot start reaction mixture of claim 26, wherein the nucleic acid polymerase is thermostable.

### Claim 30 (depends on 26)

The dual hot start reaction mixture of claim 26, wherein the nucleic acid polymerase comprises a polymerase selected from the group consisting of Taq DNA polymerase, Tfl DNA polymerase, Tfi DNA polymerase, Pfu DNA polymerase, and mutants or derivatives thereof.
